Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting?

Journal of NeuroInterventional Surgery

Volumn 2, Issue 1, 2010, Pages 50-54

  Jiang, W J ^a   Du, B ^a   Hon, S F K ^b   Jin, M ^a   Xu, X T ^a   Ma, N ^a   Gao, F ^a   Dong, K H ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY OCCLUSION; ARTICLE; BASILAR ARTERY OBSTRUCTION; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CONTROLLED STUDY; DEATH; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VERTEBRAL ARTERY STENOSIS;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; STENTS; STROKE; VERTEBROBASILAR INSUFFICIENCY;

EID: 79960012379     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/jnis.2009.000356     Document Type: Article

References (27)

1. Wong KS, Huang YN, Gao S, et al. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998;50:812-13.
2. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998;29:1389-92.
3. Qureshi AI, Ziai WC, Yahia AM, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery 2003;52:1033-40. (Pubitemid 36512965)
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16.
5. Kasner SE, Chimowitz MI, Lynn MJ, et al. Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-63.
6. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95-9. (Pubitemid 30035759)
7. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001;48:1215-23.
8. Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002;97:1294-301. (Pubitemid 35424283)
9. Lylyk P, Cohen JE, Ceratto R, et al. Endovascular reconstruction of intracranial arteries by stent placement and combined techniques. J Neurosurg 2002;97:1306-13. (Pubitemid 35424285)
10. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375-80. (Pubitemid 38697461)
11. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-92.
12. de Rochemont Rdu M, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents: initial experience. Radiology 2004;231:45-9.
13. Yu W, Smith WS, Singh V, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005;64:1055-7. (Pubitemid 40388461)
14. Hatano T, Tsukahara T, Ogino E, et al. Stenting for vertebrobasilar artery stenosis. Acta Neurochir Suppl 2005;94:137-41.
15. Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res 2005;27(Suppl 1):S95-102.
16. Jiang WJ, Srivastava T, Gao F, et al. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:1868-72. (Pubitemid 44049818)
17. Jiang WJ, Xu XT, Du B, et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420-6. (Pubitemid 46208744)
18. Jiang WJ, Xu XT, Du B, et al. Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology 2007;68:856-8. (Pubitemid 46568538)
19. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531-7. (Pubitemid 46684170)
20. Fiorella D, Chow MM, Anderson M, et al. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236-43.
21. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881-7. (Pubitemid 46568447)
22. Freitas JM, Zenteno M, Aburto-Murrieta Y, et al. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol 2007;68:378-86. (Pubitemid 47495938)
23. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic70-99% intracranial arterial stenosis. Neurology 2008;70:1518-24. (Pubitemid 351589505)
24. Groschel K, Schnaudigel S, Pilgram SM, et al. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340-7.
25. Nahab F, Lynn MJ, Kasner SE, et al. For the NIH Multicenter Wingspan Intracranial Stent Registry Study Group. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014-19.
26. Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-6. (Pubitemid 30210425)
27. Schoenfeld DA. Sample size formula for the proportional-hazards regression model. Biometrics 1983;39:499-503. (Pubitemid 14267522)